Identification of differentially expressed genes in human uterine leiomyomas using differential display

Cell Research

Volumn 12, Issue 1, 2002, Pages 39-45

  Li, Bin ^a   Sun, Mei ^a,c   He, Bin ^a,d   Yu, Jin ^b   Zhang, You Duan ^a   Zhang, Yong Lian ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b OB/GYN Hospital   (China)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Differential display (DD); Differentially expressed gene; Human S19 ribosomal protein (hRPS19); Human uterine leiomyomas; Up regulated gene in human leiomyomas

Indexed keywords

EID: 0347698482     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290108     Document Type: Article

References (29)

1. Towsend DE, Sparkes RS, McClellan MD. Unicellular histoginesis of uterine leiomyonias as detedted by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970; 107:1168-73.
2. Cramer DW. Epidemiology of myoma. Semin Reprod Endocrinol 1992; 10:320-4.
3. National Center for Health Statistics. Hysterectomies in the United States1965-1984. Bethesda, Maryland:National Center for Health Statistics, 1987; (National health survey series 13, no. 92 DHHS publication no(PHS) 1987; 88-1753.
4. Buttram VC, Reiter RC. Uterine leiomomata: Etiology, symptomatology, and management. Fertil steril 1981; 36:433-45.
5. Friedman AJ, Hoffman DI, Comite FL. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind placebo-controlled, multicenter study. Obstet Gynecol 1991; 77:720-5.
6. Brandon DD, Erickson TE, Keenan EJ, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clinical Endocrinol and Metabol 1995; 80:1876-81.
7. Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertil Steril 1991; 56:997-1000.
8. Guidice LC, Irwin JC, Dsupin BA. Insulin-like growth factor (IGF), IGF binding protein (IGFBP) and IGF receptor gene expression and IGFBP syntheis in human uterine leiomyomata. Hum Repred 1993; 8:1796-806.
9. Qingchuan D, Yong Z, Roy WT, Hui R, R. Stan W, Gregory SS, Nasser C. Suppression of transforming growth factor-b (TGF-b) and TGF-b receptor mesenger ribonuleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinology Metabolism. J Clinical Endocrinol and Metabol 1996; 81:3222-30.
10. Pandis N, Heim S, Bardi G, et al. Chromosome analysis in 96 uterine leiomyomas. Cancer Genet Cytogenet 1991; 55:11-8.
11. Ishwad CS, Ferrell RE, Davare J, Meloni AM, Sandberg AA, Surti U. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyoma. Genes Chrom Cancer 1995; 14:51-5.
12. Mark J, Havel G, Grepp C. Chromosomal patt4erns in human benign uterine leiomyomas. Cancer Genet Cytogenet 1990; 44:1-13.
13. Rein M, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. Cytogenetic abnormalities in uterine leiomyoma. Obstet Gynecol 1991; 77:923-6.
14. Wanschura S, Belge G, Stenman G, et al. Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12. Cancer Genet Cytogenet 1996; 86:39-45.
15. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257:967-71.
16. Bsuer K, Warthoe P, Reich JL. Identification of differently expressed mRNA species by an improved display technique(DDRT-PCR). Nucleic Acids Res 1993; 21:4272-8.
17. Adati N, Ito T, Koya CL. Differential display analysis of gene expression in developing embryos Xenopus Laevis. Biochmia et Biophysica Acta 1995; 1262:43-51.
18. Chomezynski P, Sacchi N. Single-step method of RNA Isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
19. Liang P, Averboukh L, Parade AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993; 21:3269-75.
20. Mager WH. Control of ribosomal protein gene expression. Biochim Biophys Acta 1988; 949(1):1-15.
21. Kenmochi N, Kawaguchi T, Rozen S, Davis E, Goodman N, Hudson TJ, Tanaka T, Page DC. A map of 75 human ribosomal protein genes. Genome Res 1998; 8(5):509-23.
22. Kondoh N, Schweinfest CW, Henderson KW, Papas TS. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 1992; 52(4):791-6.
23. Suzuki K, Olvera J, Wool IG. The primary structure of rat ribosomal protein S19. Biochimie 1990; 72(4):299-302.
24. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998; 4(12):3045-50.
25. Rhodes LD, Van-Beneden RJ. Isolation of the cDNA and characterization of mRNA expression of ribosomal protein S19 from the soft-shell clam, Mya arenaria. Gene 1997; 197(1-2):295-304.
26. Kenmochi N, Kawaguchi T, Rozen S, et al. A map of 75 human ribosomal protein genes. Genome Res 1998; 8:509-23.
27. Nishiura H, Tanase S, Sibuya Y, Nishimura T, Yamamoto T. Determination of the cross-linked residues in homodimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 1999; 79(8):915-23.
28. Shrestha A, Horino K, Nishiura H, Yamamoto T. cquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest 1999; 79(12):1629-42.
29. Willig TN, Draptchinskaia N, Dianzani I, et al. Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood 1999; 94(12):4294-306.